Celther Poland

Celther Poland begins challenge of designing stem-cell therapy for biopharmaceutical market. Currently Celther Poland is focused on development, and commercialization of cell based therapies, for the treatment of patients with Diabetes and Parkinson disease. In the future Celther Poland intends to use cell-therapy in may kinds of disorders. It is first Polish company dedicated to bring stem cells therapy in to the biopharmacy.

Celther Poland is going to provide therapy based on several strategies: physiological (somatic stem cells therapy), physiologically-biotechnological (plasticity), and biotechnological (reprogramming). These approaches are recognized by many authorities as very successful, and do not require use of embryonic stem cells. Celther Poland is strongly supported by biopharmaceutical company LEK-AM.

Contact us:
Celther Polska Sp. z o.o.
Ul. Ostrzykowizna 14 A, 05-170 Zakroczym
ul. Podwale 23, 00-261 Warszawa
Tel 022 635 80 41, Fax 022 635 76 26
awidanka@lekam.pl, piotrrieske@yahoo.com